chromosome

trends & perspectives in clinical research

goBalto Chromosome

Webinar: Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials

by Craig Morgan
14Aug2017

Save your seat for this upcoming webinar! Trial metrics are critical to risk mitigation and a preemptive weapon in the fight against the dreaded rescue study.

Webinar: Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials

Title: Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials

Description:

Metrics are central to efforts to rein in clinical trials that are either poorly initiated or have incurred unforeseen events, which place the original timelines and/or budgets at risk of overages. They also drive competitive performance among those organizations performing trials.

Business Intelligence (BI) has become an increasingly popular topic in clinical trials as clinical project managers are expected to make smarter decisions on intelligence derived from clinical trial data and sponsors/CROs are looking for ways to incorporate BI into the eClinical systems they are using to empower oversight - turning raw trail data into actionable information.

Having technology which can automate or assist in the timely monitoring of trials is a huge improvement over the current 'status quo' of manual methods such as spreadsheets, which are cumbersome and erroneous, not to mention only provide a dated snap-shot of trial performance. But how do metrics drive performance competitiveness?

In this webinar we will explore:

  • Business Intelligence: The need to make smarter decisions on intelligences derived from clinical trial data
  • Industry trends on data mining and analytics
  • The need for industry benchmarking across trials & its inherent challenges
  • Moving beyond benchmarking to gamification, efficient resource allocation, and predicative analytics or forecasting

This webinar is applicable to:

  • Sponsor and CRO roles responsible for site selection and activation
  • Sponsor and CRO roles responsible for collecting and evaluating trial metrics

When:

Tuesday, August 29
1 pm ET
10 am PT

Save my seat

Presenters:

Jeff Kasher
JEFFREY KASHER
President
Patients Can't Wait
Jeff Kasher is a known pharmaceutical development change expert with 28 years of experience at Eli Lilly. He is passionate for improving outcomes, bringing patients and research sites into the development process, and dramatically decreasing time to market. His expertise includes novel product development from bench through market launch, research and clinical trial leadership, innovation center start up as well as new industry paradigm creation.

Jeff is President of Patients Can't Wait, Chairman of Advisory Board for DrugDev as well as member of Advisory Board of TrialReach, Cytolon, and goBalto. He sits on the DPharm steering committee and faculty, and is a member of Linking Leaders. In 2013 CenterWatch Jeff was named one of the "20 Innovators Changing the Face of the Clinical Trials Industry." He received a B.S. in Chemistry from Franklin & Marshall College, a Ph.D. in Pharmacology from the State University of New York, and a Post-Doctoral Fellowship in Physiology at Yale University School of Medicine.
Barry Milton
BARRY MILTON
Head of Business Operations
Novartis
Barry is a clinical trial and operations management expert. His experiences as an Oncology nurse, clinical trial coordinator and his senior management roles at Novartis, Roche, Merck, and AstraZeneca provides him with a well-rounded set of skills and experiences in the clinical trial space. His passion is transforming study management and trial execution processes through the creation of optimized business processes, which are supported by facilitating systems, which allow sponsor and investigator teams to meet their patient and clinical program goals faster and more efficiently.
Rob Wynden
ROB WYNDEN
VP Technology & Engineering
goBalto
Rob has been a computer scientist and programmer for over 30 years in the scientific programming, e-commerce, biotech, and health care industries. He implemented study startup and CTMS functionality at 9 bay are biotech companies, and invented a method that allows medical and biotech organizations to use cloud-based analytics to monitor patient data. He holds a BS in Computer Engineering from Sacramento State University and a PhD in Biological and Biomedical Clinical Informatics from UCSF.

Recent Posts